South Korea Computer Vision Healthcare Market

ID: MRFR/HC/49666-HCR
200 Pages
Vikita Thakur
Last Updated: February 06, 2026
South Korea Computer Vision Healthcare Market Research Report: Size, Share, Trend Analysis By Applications (Medical Imaging, Surgical Robotics, Disease Diagnosis, Patient Monitoring, Drug Discovery), By Technology (Deep Learning, Machine Learning, Image Processing, Facial Recognition, 3D Imaging), By End Use (Hospitals, Diagnostic Centers, Research Laboratories, Pharmaceutical Companies, Healthcare IT) and By Component (Software, Hardware, Services) - Growth Outlook & Industry Forecast 2025 To 2035
South Korea Computer Vision Healthcare Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)14.54%
2024 Market Size$ 47.19 Million
2025 Market Size$ 54.05 Million
2035 Market Size$ 210.08 Million
Key Players
Siemens Healthineers
GE Healthcare
Philips Healthcare
IBM Watson Health
Canon Medical Systems
NVIDIA Corporation
Trends
  • Increased Adoption of AI in Diagnostics
  • Government Support for Smart Healthcare Initiatives
  • Focus on Data Security and Privacy
Opportunities
  • Increased Focus on Preventive Healthcare
  • Rising Demand for Telemedicine Solutions
  • Growing Investment in Health Tech Startups
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Application (USD Million)
      1. 4.1.1 Medical Imaging
      2. 4.1.2 Surgical Robotics
      3. 4.1.3 Disease Diagnosis
      4. 4.1.4 Patient Monitoring
      5. 4.1.5 Drug Discovery
    2. 4.2 Pharmaceutical, BY Technology (USD Million)
      1. 4.2.1 Deep Learning
      2. 4.2.2 Machine Learning
      3. 4.2.3 Image Processing
      4. 4.2.4 Facial Recognition
      5. 4.2.5 3D Imaging
    3. 4.3 Pharmaceutical, BY End Use (USD Million)
      1. 4.3.1 Hospitals
      2. 4.3.2 Diagnostic Centers
      3. 4.3.3 Research Laboratories
      4. 4.3.4 Pharmaceutical Companies
      5. 4.3.5 Healthcare IT
    4. 4.4 Pharmaceutical, BY Component (USD Million)
      1. 4.4.1 Software
      2. 4.4.2 Hardware
      3. 4.4.3 Services
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Siemens Healthineers (DE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 GE Healthcare (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Philips Healthcare (NL)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 IBM Watson Health (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Canon Medical Systems (JP)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 NVIDIA Corporation (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Zebra Medical Vision (IL)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Aidoc (IL)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    3. 6.3 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
    4. 6.4 SOUTH KOREA MARKET ANALYSIS BY END USE
    5. 6.5 SOUTH KOREA MARKET ANALYSIS BY COMPONENT
    6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
    9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    12. 6.12 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
    13. 6.13 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
    14. 6.14 PHARMACEUTICAL, BY TECHNOLOGY, 2024 (% SHARE)
    15. 6.15 PHARMACEUTICAL, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
    16. 6.16 PHARMACEUTICAL, BY END USE, 2024 (% SHARE)
    17. 6.17 PHARMACEUTICAL, BY END USE, 2024 TO 2035 (USD Million)
    18. 6.18 PHARMACEUTICAL, BY COMPONENT, 2024 (% SHARE)
    19. 6.19 PHARMACEUTICAL, BY COMPONENT, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million)
      3. 7.2.3 BY END USE, 2025-2035 (USD Million)
      4. 7.2.4 BY COMPONENT, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

South Korea South Korea Computer Vision Healthcare Market Segmentation

South Korea Computer Vision Healthcare Market By Application (USD Million, 2025-2035)

  • Medical Imaging
  • Surgical Robotics
  • Disease Diagnosis
  • Patient Monitoring
  • Drug Discovery

South Korea Computer Vision Healthcare Market By Technology (USD Million, 2025-2035)

  • Deep Learning
  • Machine Learning
  • Image Processing
  • Facial Recognition
  • 3D Imaging

South Korea Computer Vision Healthcare Market By End Use (USD Million, 2025-2035)

  • Hospitals
  • Diagnostic Centers
  • Research Laboratories
  • South Korea Computer Vision Healthcare Market Companies
  • South Korea Computer Vision Healthcare Market IT

South Korea Computer Vision Healthcare Market By Component (USD Million, 2025-2035)

  • Software
  • Hardware
  • Services

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.